What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Prescription Drugs

PUBLISHER: QYResearch | PRODUCT CODE: 1873696

PUBLISHER: QYResearch | PRODUCT CODE: 1873696

Apomorphine Hydrochloride - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

PUBLISHED: October 24, 2025

PAGES: 114 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

The global market for Apomorphine Hydrochloride was estimated to be worth US$ 150 million in 2024 and is forecast to a readjusted size of US$ 209 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Apomorphine Hydrochloride cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and a-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.

The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025. Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%. Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%. Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report aims to provide a comprehensive presentation of the global market for Apomorphine Hydrochloride, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Apomorphine Hydrochloride by region & country, by Type, and by Application.

The Apomorphine Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Hydrochloride.

Market Segmentation

By Company

Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
STADA Arzneimittel
Aguettant
Italfarmaco
Sumitomo Pharma
Hubei Keyi Pharma

Segment by Type

Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)

Segment by Application

Parkinson Disease
Erectile Dysfunction

By Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Apomorphine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Apomorphine Hydrochloride in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

1 Market Overview

1.1 Apomorphine Hydrochloride Product Introduction
1.2 Global Apomorphine Hydrochloride Market Size Forecast
- 1.2.1 Global Apomorphine Hydrochloride Sales Value (2020-2031)
- 1.2.2 Global Apomorphine Hydrochloride Sales Volume (2020-2031)
- 1.2.3 Global Apomorphine Hydrochloride Sales Price (2020-2031)
1.3 Apomorphine Hydrochloride Market Trends & Drivers
- 1.3.1 Apomorphine Hydrochloride Industry Trends
- 1.3.2 Apomorphine Hydrochloride Market Drivers & Opportunity
- 1.3.3 Apomorphine Hydrochloride Market Challenges
- 1.3.4 Apomorphine Hydrochloride Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Apomorphine Hydrochloride Players Revenue Ranking (2024)
2.2 Global Apomorphine Hydrochloride Revenue by Company (2020-2025)
2.3 Global Apomorphine Hydrochloride Players Sales Volume Ranking (2024)
2.4 Global Apomorphine Hydrochloride Sales Volume by Company Players (2020-2025)
2.5 Global Apomorphine Hydrochloride Average Price by Company (2020-2025)
2.6 Key Manufacturers Apomorphine Hydrochloride Manufacturing Base and Headquarters
2.7 Key Manufacturers Apomorphine Hydrochloride Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Apomorphine Hydrochloride
2.9 Apomorphine Hydrochloride Market Competitive Analysis
- 2.9.1 Apomorphine Hydrochloride Market Concentration Rate (2020-2025)
- 2.9.2 Global 5 and 10 Largest Manufacturers by Apomorphine Hydrochloride Revenue in 2024
- 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Apomorphine Hydrochloride as of 2024)
2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type
- 3.1.1 Injection
- 3.1.2 Tablets
- 3.1.3 Thinfilm
- 3.1.4 Nasal Powder (Pipeline)
3.2 Global Apomorphine Hydrochloride Sales Value by Type
- 3.2.1 Global Apomorphine Hydrochloride Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Apomorphine Hydrochloride Sales Value, by Type (2020-2031)
- 3.2.3 Global Apomorphine Hydrochloride Sales Value, by Type (%) (2020-2031)
3.3 Global Apomorphine Hydrochloride Sales Volume by Type
- 3.3.1 Global Apomorphine Hydrochloride Sales Volume by Type (2020 VS 2024 VS 2031)
- 3.3.2 Global Apomorphine Hydrochloride Sales Volume, by Type (2020-2031)
- 3.3.3 Global Apomorphine Hydrochloride Sales Volume, by Type (%) (2020-2031)
3.4 Global Apomorphine Hydrochloride Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application
- 4.1.1 Parkinson Disease
- 4.1.2 Erectile Dysfunction
4.2 Global Apomorphine Hydrochloride Sales Value by Application
- 4.2.1 Global Apomorphine Hydrochloride Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Apomorphine Hydrochloride Sales Value, by Application (2020-2031)
- 4.2.3 Global Apomorphine Hydrochloride Sales Value, by Application (%) (2020-2031)
4.3 Global Apomorphine Hydrochloride Sales Volume by Application
- 4.3.1 Global Apomorphine Hydrochloride Sales Volume by Application (2020 VS 2024 VS 2031)
- 4.3.2 Global Apomorphine Hydrochloride Sales Volume, by Application (2020-2031)
- 4.3.3 Global Apomorphine Hydrochloride Sales Volume, by Application (%) (2020-2031)
4.4 Global Apomorphine Hydrochloride Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Apomorphine Hydrochloride Sales Value by Region
- 5.1.1 Global Apomorphine Hydrochloride Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Apomorphine Hydrochloride Sales Value by Region (2020-2025)
- 5.1.3 Global Apomorphine Hydrochloride Sales Value by Region (2026-2031)
- 5.1.4 Global Apomorphine Hydrochloride Sales Value by Region (%), (2020-2031)
5.2 Global Apomorphine Hydrochloride Sales Volume by Region
- 5.2.1 Global Apomorphine Hydrochloride Sales Volume by Region: 2020 VS 2024 VS 2031
- 5.2.2 Global Apomorphine Hydrochloride Sales Volume by Region (2020-2025)
- 5.2.3 Global Apomorphine Hydrochloride Sales Volume by Region (2026-2031)
- 5.2.4 Global Apomorphine Hydrochloride Sales Volume by Region (%), (2020-2031)
5.3 Global Apomorphine Hydrochloride Average Price by Region (2020-2031)
5.4 North America
- 5.4.1 North America Apomorphine Hydrochloride Sales Value, 2020-2031
- 5.4.2 North America Apomorphine Hydrochloride Sales Value by Country (%), 2024 VS 2031
5.5 Europe
- 5.5.1 Europe Apomorphine Hydrochloride Sales Value, 2020-2031
- 5.5.2 Europe Apomorphine Hydrochloride Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
- 5.6.1 Asia Pacific Apomorphine Hydrochloride Sales Value, 2020-2031
- 5.6.2 Asia Pacific Apomorphine Hydrochloride Sales Value by Region (%), 2024 VS 2031
5.7 South America
- 5.7.1 South America Apomorphine Hydrochloride Sales Value, 2020-2031
- 5.7.2 South America Apomorphine Hydrochloride Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
- 5.8.1 Middle East & Africa Apomorphine Hydrochloride Sales Value, 2020-2031
- 5.8.2 Middle East & Africa Apomorphine Hydrochloride Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Apomorphine Hydrochloride Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Apomorphine Hydrochloride Sales Value and Sales Volume
- 6.2.1 Key Countries/Regions Apomorphine Hydrochloride Sales Value, 2020-2031
- 6.2.2 Key Countries/Regions Apomorphine Hydrochloride Sales Volume, 2020-2031
6.3 United States
- 6.3.1 United States Apomorphine Hydrochloride Sales Value, 2020-2031
- 6.3.2 United States Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031
6.4 Europe
- 6.4.1 Europe Apomorphine Hydrochloride Sales Value, 2020-2031
- 6.4.2 Europe Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031
6.5 China
- 6.5.1 China Apomorphine Hydrochloride Sales Value, 2020-2031
- 6.5.2 China Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031
6.6 Japan
- 6.6.1 Japan Apomorphine Hydrochloride Sales Value, 2020-2031
- 6.6.2 Japan Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031
6.7 South Korea
- 6.7.1 South Korea Apomorphine Hydrochloride Sales Value, 2020-2031
- 6.7.2 South Korea Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
- 6.8.1 Southeast Asia Apomorphine Hydrochloride Sales Value, 2020-2031
- 6.8.2 Southeast Asia Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031
6.9 India
- 6.9.1 India Apomorphine Hydrochloride Sales Value, 2020-2031
- 6.9.2 India Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Supernus Pharmaceuticals
- 7.1.1 Supernus Pharmaceuticals Company Information
- 7.1.2 Supernus Pharmaceuticals Introduction and Business Overview
- 7.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Offerings
- 7.1.5 Supernus Pharmaceuticals Recent Development
7.2 Britannia Pharmaceuticals STADA
- 7.2.1 Britannia Pharmaceuticals STADA Company Information
- 7.2.2 Britannia Pharmaceuticals STADA Introduction and Business Overview
- 7.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Offerings
- 7.2.5 Britannia Pharmaceuticals STADA Recent Development
7.3 Ever Pharma
- 7.3.1 Ever Pharma Company Information
- 7.3.2 Ever Pharma Introduction and Business Overview
- 7.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Ever Pharma Apomorphine Hydrochloride Product Offerings
- 7.3.5 Ever Pharma Recent Development
7.4 Evolan Pharma AB (PharmSwed)
- 7.4.1 Evolan Pharma AB (PharmSwed) Company Information
- 7.4.2 Evolan Pharma AB (PharmSwed) Introduction and Business Overview
- 7.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Offerings
- 7.4.5 Evolan Pharma AB (PharmSwed) Recent Development
7.5 Tianjin Tianwei Pharmaceutical
- 7.5.1 Tianjin Tianwei Pharmaceutical Company Information
- 7.5.2 Tianjin Tianwei Pharmaceutical Introduction and Business Overview
- 7.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Offerings
- 7.5.5 Tianjin Tianwei Pharmaceutical Recent Development
7.6 Sunovion
- 7.6.1 Sunovion Company Information
- 7.6.2 Sunovion Introduction and Business Overview
- 7.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Sunovion Apomorphine Hydrochloride Product Offerings
- 7.6.5 Sunovion Recent Development
7.7 STADA Arzneimittel
- 7.7.1 STADA Arzneimittel Company Information
- 7.7.2 STADA Arzneimittel Introduction and Business Overview
- 7.7.3 STADA Arzneimittel Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.7.4 STADA Arzneimittel Apomorphine Hydrochloride Product Offerings
- 7.7.5 STADA Arzneimittel Recent Development
7.8 Aguettant
- 7.8.1 Aguettant Company Information
- 7.8.2 Aguettant Introduction and Business Overview
- 7.8.3 Aguettant Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.8.4 Aguettant Apomorphine Hydrochloride Product Offerings
- 7.8.5 Aguettant Recent Development
7.9 Italfarmaco
- 7.9.1 Italfarmaco Company Information
- 7.9.2 Italfarmaco Introduction and Business Overview
- 7.9.3 Italfarmaco Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.9.4 Italfarmaco Apomorphine Hydrochloride Product Offerings
- 7.9.5 Italfarmaco Recent Development
7.10 Sumitomo Pharma
- 7.10.1 Sumitomo Pharma Company Information
- 7.10.2 Sumitomo Pharma Introduction and Business Overview
- 7.10.3 Sumitomo Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.10.4 Sumitomo Pharma Apomorphine Hydrochloride Product Offerings
- 7.10.5 Sumitomo Pharma Recent Development
7.11 Hubei Keyi Pharma
- 7.11.1 Hubei Keyi Pharma Company Information
- 7.11.2 Hubei Keyi Pharma Introduction and Business Overview
- 7.11.3 Hubei Keyi Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.11.4 Hubei Keyi Pharma Apomorphine Hydrochloride Product Offerings
- 7.11.5 Hubei Keyi Pharma Recent Development

8 Industry Chain Analysis

8.1 Apomorphine Hydrochloride Industrial Chain
8.2 Apomorphine Hydrochloride Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
- 8.5.1 Apomorphine Hydrochloride Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Apomorphine Hydrochloride Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
  - 10.1.1.1 Research Programs/Design
  - 10.1.1.2 Market Size Estimation
  - 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
  - 10.1.2.1 Secondary Sources
  - 10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables

Table 1. Apomorphine Hydrochloride Market Trends
Table 2. Apomorphine Hydrochloride Market Drivers & Opportunity
Table 3. Apomorphine Hydrochloride Market Challenges
Table 4. Apomorphine Hydrochloride Market Restraints
Table 5. Global Apomorphine Hydrochloride Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Apomorphine Hydrochloride Revenue Market Share by Company (2020-2025)
Table 7. Global Apomorphine Hydrochloride Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Apomorphine Hydrochloride Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Apomorphine Hydrochloride Price by Company (2020-2025) & (USD/Unit)
Table 10. Key Manufacturers Apomorphine Hydrochloride Manufacturing Base and Headquarters
Table 11. Key Manufacturers Apomorphine Hydrochloride Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Apomorphine Hydrochloride
Table 13. Global Apomorphine Hydrochloride Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Apomorphine Hydrochloride as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Apomorphine Hydrochloride Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Apomorphine Hydrochloride Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Apomorphine Hydrochloride Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Apomorphine Hydrochloride Sales Market Share in Value by Type (2020-2025)
Table 20. Global Apomorphine Hydrochloride Sales Market Share in Value by Type (2026-2031)
Table 21. Global Apomorphine Hydrochloride Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Apomorphine Hydrochloride Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Apomorphine Hydrochloride Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Apomorphine Hydrochloride Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Apomorphine Hydrochloride Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Apomorphine Hydrochloride Price by Type (2020-2025) & (USD/Unit)
Table 27. Global Apomorphine Hydrochloride Price by Type (2026-2031) & (USD/Unit)
Table 28. Global Apomorphine Hydrochloride Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Apomorphine Hydrochloride Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Apomorphine Hydrochloride Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Apomorphine Hydrochloride Sales Market Share in Value by Application (2020-2025)
Table 32. Global Apomorphine Hydrochloride Sales Market Share in Value by Application (2026-2031)
Table 33. Global Apomorphine Hydrochloride Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Apomorphine Hydrochloride Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Apomorphine Hydrochloride Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Apomorphine Hydrochloride Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Apomorphine Hydrochloride Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Apomorphine Hydrochloride Price by Application (2020-2025) & (USD/Unit)
Table 39. Global Apomorphine Hydrochloride Price by Application (2026-2031) & (USD/Unit)
Table 40. Global Apomorphine Hydrochloride Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Apomorphine Hydrochloride Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Apomorphine Hydrochloride Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Apomorphine Hydrochloride Sales Value by Region (2020-2025) & (%)
Table 44. Global Apomorphine Hydrochloride Sales Value by Region (2026-2031) & (%)
Table 45. Global Apomorphine Hydrochloride Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Apomorphine Hydrochloride Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Apomorphine Hydrochloride Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Apomorphine Hydrochloride Sales Volume by Region (2020-2025) & (%)
Table 49. Global Apomorphine Hydrochloride Sales Volume by Region (2026-2031) & (%)
Table 50. Global Apomorphine Hydrochloride Average Price by Region (2020-2025) & (USD/Unit)
Table 51. Global Apomorphine Hydrochloride Average Price by Region (2026-2031) & (USD/Unit)
Table 52. Key Countries/Regions Apomorphine Hydrochloride Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Apomorphine Hydrochloride Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Apomorphine Hydrochloride Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Apomorphine Hydrochloride Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Apomorphine Hydrochloride Sales Volume, (2026-2031) & (K Units)
Table 57. Supernus Pharmaceuticals Company Information
Table 58. Supernus Pharmaceuticals Introduction and Business Overview
Table 59. Supernus Pharmaceuticals Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Supernus Pharmaceuticals Apomorphine Hydrochloride Product Offerings
Table 61. Supernus Pharmaceuticals Recent Development
Table 62. Britannia Pharmaceuticals STADA Company Information
Table 63. Britannia Pharmaceuticals STADA Introduction and Business Overview
Table 64. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Offerings
Table 66. Britannia Pharmaceuticals STADA Recent Development
Table 67. Ever Pharma Company Information
Table 68. Ever Pharma Introduction and Business Overview
Table 69. Ever Pharma Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Ever Pharma Apomorphine Hydrochloride Product Offerings
Table 71. Ever Pharma Recent Development
Table 72. Evolan Pharma AB (PharmSwed) Company Information
Table 73. Evolan Pharma AB (PharmSwed) Introduction and Business Overview
Table 74. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Offerings
Table 76. Evolan Pharma AB (PharmSwed) Recent Development
Table 77. Tianjin Tianwei Pharmaceutical Company Information
Table 78. Tianjin Tianwei Pharmaceutical Introduction and Business Overview
Table 79. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Offerings
Table 81. Tianjin Tianwei Pharmaceutical Recent Development
Table 82. Sunovion Company Information
Table 83. Sunovion Introduction and Business Overview
Table 84. Sunovion Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Sunovion Apomorphine Hydrochloride Product Offerings
Table 86. Sunovion Recent Development
Table 87. STADA Arzneimittel Company Information
Table 88. STADA Arzneimittel Introduction and Business Overview
Table 89. STADA Arzneimittel Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. STADA Arzneimittel Apomorphine Hydrochloride Product Offerings
Table 91. STADA Arzneimittel Recent Development
Table 92. Aguettant Company Information
Table 93. Aguettant Introduction and Business Overview
Table 94. Aguettant Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Aguettant Apomorphine Hydrochloride Product Offerings
Table 96. Aguettant Recent Development
Table 97. Italfarmaco Company Information
Table 98. Italfarmaco Introduction and Business Overview
Table 99. Italfarmaco Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Italfarmaco Apomorphine Hydrochloride Product Offerings
Table 101. Italfarmaco Recent Development
Table 102. Sumitomo Pharma Company Information
Table 103. Sumitomo Pharma Introduction and Business Overview
Table 104. Sumitomo Pharma Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Sumitomo Pharma Apomorphine Hydrochloride Product Offerings
Table 106. Sumitomo Pharma Recent Development
Table 107. Hubei Keyi Pharma Company Information
Table 108. Hubei Keyi Pharma Introduction and Business Overview
Table 109. Hubei Keyi Pharma Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Hubei Keyi Pharma Apomorphine Hydrochloride Product Offerings
Table 111. Hubei Keyi Pharma Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Apomorphine Hydrochloride Downstream Customers
Table 115. Apomorphine Hydrochloride Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Apomorphine Hydrochloride Product Picture
Figure 2. Global Apomorphine Hydrochloride Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Apomorphine Hydrochloride Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Apomorphine Hydrochloride Sales Volume (2020-2031) & (K Units)
Figure 5. Global Apomorphine Hydrochloride Sales Price (2020-2031) & (USD/Unit)
Figure 6. Apomorphine Hydrochloride Report Years Considered
Figure 7. Global Apomorphine Hydrochloride Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Apomorphine Hydrochloride Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Apomorphine Hydrochloride Revenue in 2024
Figure 10. Apomorphine Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Injection Picture
Figure 12. Tablets Picture
Figure 13. Thinfilm Picture
Figure 14. Nasal Powder (Pipeline) Picture
Figure 15. Global Apomorphine Hydrochloride Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Apomorphine Hydrochloride Sales Value Market Share by Type, 2024 & 2031
Figure 17. Global Apomorphine Hydrochloride Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 18. Global Apomorphine Hydrochloride Sales Volume Market Share by Type, 2024 & 2031
Figure 19. Global Apomorphine Hydrochloride Price by Type (2020-2031) & (USD/Unit)
Figure 20. Product Picture of Parkinson Disease
Figure 21. Product Picture of Erectile Dysfunction
Figure 22. Global Apomorphine Hydrochloride Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Apomorphine Hydrochloride Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Apomorphine Hydrochloride Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 25. Global Apomorphine Hydrochloride Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Apomorphine Hydrochloride Price by Application (2020-2031) & (USD/Unit)
Figure 27. North America Apomorphine Hydrochloride Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Apomorphine Hydrochloride Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Apomorphine Hydrochloride Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Apomorphine Hydrochloride Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Apomorphine Hydrochloride Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Apomorphine Hydrochloride Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Apomorphine Hydrochloride Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Apomorphine Hydrochloride Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Apomorphine Hydrochloride Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Apomorphine Hydrochloride Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Apomorphine Hydrochloride Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Apomorphine Hydrochloride Sales Volume (%), (2020-2031)
Figure 39. United States Apomorphine Hydrochloride Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Apomorphine Hydrochloride Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Apomorphine Hydrochloride Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Apomorphine Hydrochloride Sales Value by Application (%), 2024 VS 2031
Figure 45. China Apomorphine Hydrochloride Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
Figure 47. China Apomorphine Hydrochloride Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Apomorphine Hydrochloride Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Apomorphine Hydrochloride Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Apomorphine Hydrochloride Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Apomorphine Hydrochloride Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Apomorphine Hydrochloride Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Apomorphine Hydrochloride Sales Value by Application (%), 2024 VS 2031
Figure 57. India Apomorphine Hydrochloride Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
Figure 59. India Apomorphine Hydrochloride Sales Value by Application (%), 2024 VS 2031
Figure 60. Apomorphine Hydrochloride Industrial Chain
Figure 61. Apomorphine Hydrochloride Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed